Proteomics International Laboratories Ltd (PIQ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH285685D
- Pages: 21
- September 2018
- Total Views:1140
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics International developed PromarkerD, a predictive test for the diagnosis of diabetic kidney disease. Its analytical services include pharmacokinetic testing, biosimilars or biologic drug characterization, and proteome mapping. The company works on the discovery of painkillers and antibiotics drug compounds from animal venom, as part of its drug discovery efforts. Proteomics International is headquartered in Nedlands, Western Australia, Australia.
Proteomics International Laboratories Ltd (PIQ)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 11
Proteomics International Lab Enters into Agreement with Dimerix 12
Proteomics International Labs to Enter into Agreement with Linear Clinical Research 13
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 14
Acquisition 15
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd-Key Competitors 16
Proteomics International Laboratories Ltd-Key Employees 17
Proteomics International Laboratories Ltd-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Legal and Regulatory 19
May 09, 2017: Proteomics International becomes world's most accredited protein testing laboratory, launches pharmacokinetic and companion diagnostic testing for clinical trials 19
Product News 20
Jan 10, 2018: International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC 54458-888-16; Lot 117099A 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List Of Figure
List of Figures
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 11
Proteomics International Lab Enters into Agreement with Dimerix 12
Proteomics International Labs to Enter into Agreement with Linear Clinical Research 13
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 14
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd, Key Competitors 16
Proteomics International Laboratories Ltd, Key Employees 17
Proteomics International Laboratories Ltd, Other Locations 18
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Proteomics International Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of proteins. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas; diagnostics, analytical services and drug discovery. Proteomics International developed PromarkerD, a predictive test for the diagnosis of diabetic kidney disease. Its analytical services include pharmacokinetic testing, biosimilars or biologic drug characterization, and proteome mapping. The company works on the discovery of painkillers and antibiotics drug compounds from animal venom, as part of its drug discovery efforts. Proteomics International is headquartered in Nedlands, Western Australia, Australia.
Proteomics International Laboratories Ltd (PIQ)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 11
Proteomics International Lab Enters into Agreement with Dimerix 12
Proteomics International Labs to Enter into Agreement with Linear Clinical Research 13
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 14
Acquisition 15
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd-Key Competitors 16
Proteomics International Laboratories Ltd-Key Employees 17
Proteomics International Laboratories Ltd-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Legal and Regulatory 19
May 09, 2017: Proteomics International becomes world's most accredited protein testing laboratory, launches pharmacokinetic and companion diagnostic testing for clinical trials 19
Product News 20
Jan 10, 2018: International Laboratories, LLC Issues Voluntary Nationwide Recall of one (1) Lot of Clopidogrel Tablets USP, 75 mg packaged in bottles of 30 tablets Due to Mislabeling NDC 54458-888-16; Lot 117099A 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List Of Figure
List of Figures
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Proteomics International Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Proteomics International Laboratories Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Proteomics International Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Proteomics International Labs to Enter into Partnership with CPR Pharma Services 11
Proteomics International Lab Enters into Agreement with Dimerix 12
Proteomics International Labs to Enter into Agreement with Linear Clinical Research 13
Proteomics International Enters Into Agreement With inVentiv Health For Biosimilars Development 14
Proteomics International Labs to Acquire 10% Stake in CPR Pharma Services 15
Proteomics International Laboratories Ltd, Key Competitors 16
Proteomics International Laboratories Ltd, Key Employees 17
Proteomics International Laboratories Ltd, Other Locations 18
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Proteomics International Laboratories Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.